학술논문
Correction to: A phase II/III randomized clinical trial of CisPlatin plUs Gemcitabine and Nabpaclitaxel (GAP) as pReoperative chemotherapy versus immediate resection in patIents with resecTable BiliarY tract cancers (BTC) at high risk for recurrence: PURITY study.
Document Type
Author
Niger M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian, 1, Milan, 20133, Italy. Monica.niger@istitutotumori.mi.it.; Nichetti F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian, 1, Milan, 20133, Italy.; Computational Oncology, Molecular Diagnostics Program, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Fornaro L; Medical Oncology Unit, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.; Pircher C; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian, 1, Milan, 20133, Italy.; Morano F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian, 1, Milan, 20133, Italy.; Palermo F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian, 1, Milan, 20133, Italy.; Rimassa L; Department of Biomedical Sciences, Pieve Emanuele (Milan), Humanitas University, Milan, Italy.; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.; Pressiani T; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.; Berardi R; Clinica Di Oncologia Medica, A.O.U. Delle Marche, Università Politecnica Delle Marche, Ancona, Italy.; Gardini AC; Vita-Salute San Rafaele University, Milan, Italy.; Department of Medical Oncology, San Rafaele Scientifc Institute IRCCS, Milan, Italy.; Sperti E; Department of Oncology, University of Turin, AO Ordine Mauriziano Hospital, Turin, Italy.; Salvatore L; Oncologia Medica, Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 11Oncologia Medica, Rome, Italy.; Oncologia Medica, Università Cattolica del Sacro Cuore, Rome, Italy.; Melisi D; Molecular Clinical Oncology Research Unit, Università Degli Studi Di Verona, Verona, Italy.; Investigational Cancer Therapeutics Clinical Unit, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.; Bergamo F; Medical Oncology 1 Veneto Institute of Oncology IOV-IRCCS, Padua, Italy.; Siena S; Department of Hematology Oncology, and Molecular Medicine, Grande Ospedale Metropolitano Niguarda, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Mosconi S; Medical Oncology Unit, Giovanni XXIII Hospital, Bergamo, Italy.; Longarini R; San Gerardo Hospital, Monza, Italy.; Arcangeli G; Department of Medical Oncology, ASST Spedali Civili, Brescia, Italy.; Corallo S; Medical Oncology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.; Delliponti L; Medical Oncology Unit, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.; Tamberi S; Department of Medical Oncology, Ospedale Santa Maria Delle Croci, Ravenna AUSL Romagna, Ravenna, Italy.; Fea E; Department of Medical Oncology, S. Croce E Carle Teaching Hospital, Cuneo, Italy.; Brandi G; Medical Oncology, IRCCS Azienda Ospedaliera, Universitaria Di Bologna, Bologna, Italy.; Rapposelli IG; Department of Medical Oncology, IRCCS Istituto Romagnolo Per Lo Studio Dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Salati M; Oncology Unit, University Hospital of Modena, Modena Cancer Centre, Modena, Italy.; Baili P; Department of Epidemiology and Data Science, Data Science Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Miceli R; Biostatistics for Clinical Research Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Ljevar S; Biostatistics for Clinical Research Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Cavallo I; Scientifc Directorate, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Sottotetti E; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian, 1, Milan, 20133, Italy.; Martinetti A; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian, 1, Milan, 20133, Italy.; Busset MDD; Department of Surgery, Division of HPB, General Surgery and Liver Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Sposito C; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Department of Surgery, Division of HPB, General Surgery and Liver Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Di Bartolomeo M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian, 1, Milan, 20133, Italy.; Pietrantonio F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian, 1, Milan, 20133, Italy.; de Braud F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G. Venezian, 1, Milan, 20133, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Mazzaferro V; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Department of Surgery, Division of HPB, General Surgery and Liver Transplantation, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
Source
Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407 (Electronic) Linking ISSN: 14712407 NLM ISO Abbreviation: BMC Cancer Subsets: PubMed not MEDLINE; MEDLINE
Subject
Language
English